Xerox’s (NASDAQ:XRX) Q2 CY2026 Sales Top Estimates, Stock Jumps 20.3%
Xerox (XRX) reported Q2 CY2026 revenue of $1.92 billion, up 22% year on year, topping Wall Street estimates by 1.2%. The company projected full-year revenue around $7.6 billion. Adjusted EPS was $0.38, above analysts’ consensus. Shares rose about 20.3% to $3.24 after the release.
How this was made
The 30-second read
Why it matters
Traders can use the reported Q2 beat and the stated full-year revenue expectation (~$7.6B) to reassess near-term estimates, while the cited expectation of a 3.1% revenue decline over the next 12 months is a key counterweight.
Market read
A same-quarter revenue and EPS beat triggered a large single-day stock move (+20.3%), but forward revenue expectations described in the article are less supportive.
What to watch
Adjusted operating margin fell to 2.1% (down 1.7pp YoY) and the article notes long-run EPS underperformance, which could limit sustained multiple expansion despite the beat.
Background
The article frames Xerox’s Q2 as a beat versus Wall Street on both revenue and adjusted EPS, with discussion of longer-term revenue and EPS trends.
Ticker impact
Xerox reported Q2 CY2026 sales up 22% to $1.92B, topping Wall Street estimates by 1.2%, and shares jumped 20.3% after the release.
Likely supports continued upside momentum short term, but upside may fade if traders focus on the guided/expected revenue decline over the next 12 months.
The text provides concrete Q2 beat figures and a same-day +20.3% move, plus forward-looking revenue expectations that are not clearly bullish.
Market effects
Signals modest demand resilience in document management/office services, though guidance and expected next-12-month revenue decline temper sector optimism.
No specific regional effects mentioned beyond global operations.
No explicit global macro or international policy link stated.
Counterpoint
The revenue beat may be partly offset by weaker forward expectations, so the stock pop could reverse if investors reprice the next-12-month growth outlook.
Key entities
- public_companyXerox
Reported Q2 CY2026 sales of $1.92B (+22% YoY) and adjusted EPS of $0.38, and guided full-year revenue to around $7.6B.
